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S T R A T E G I C   F O C U S  
Since March 2000, CDC has worked with the Kenya Ministry of Health (MOH), local and international 
partners to support: 
Comprehensive HIV & TB Care and Treatment:  Antiretroviral therapy (ART), treatment for TB and 
treatment of other opportunistic infections in HIV infected adults and children 
HIV and TB Prevention: Prevention of mother-to-child transmission, voluntary medical male 
circumcision, HIV testing and counseling, evidence-based behavioral interventions, prevention programs 
for key populations, prevention of TB in HIV-infected patients through Isoniazid preventive therapy (IPT) 
and TB infection control 
Laboratory Systems and Networks Strengthening: Laboratory accreditation and training, HIV testing, 
drug resistance testing, early infant diagnosis, and blood safety and infection control for healthcare and 
laboratory facilities 
HIV Surveillance and Epidemiology: Public health research and planning and implementation of HIV 
surveillance systems 
Health Systems and Evaluation:  Health systems strengthening, program monitoring and evaluation, 
and health information systems 
K E Y   A C T I V I T I E S   A N D   A C C O M P L I S H M E N T S 
HIV Care/Treatment and Prevention: 
• CDC Kenya’s support of more than 561,000 people on ART, represents a 99% achievement rate 
against the fiscal year (FY) 2016 target of 568,723 
• Over 30,000 HIV-positive pregnant women are receiving ART which represents over 50% of 
the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) year achievement of 56,736  
• Over 176,000 men and boys were voluntarily medically circumcised, representing a 119% 
achievement rate against the FY 2016 target of 147,246 
TB Care and Prevention: 
• More than half of the people living with HIV in care under CDC-supported projects were put 
on IPT, which reduces the risk of TB by 65% and up to 80% when combined with ART 
• 96% of the 10,495 HIV infected TB patients treated in CDC-supported sites were on ART during 
TB treatment 
HIV Surveillance & Epidemiology:  
• CDC worked with the Kenya Ministry of Health to use an innovative approach to HIV 
surveillance study at mortuaries in Nairobi to establish the proportion of deaths that are 
infected with HIV or caused by HIV. This study found that 19.5% of deaths among those 
surveilled were HIV-positive. 
Laboratory Systems Strengthening:  
• In 2010, only 3 medical laboratories were internationally accredited.  
• Through CDC’s intensive work with its implementing partners and the MOH, 25 medical 
laboratories have obtained accreditation between 2010 and 2016. 
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Country Quick Facts 
 




46.05 million (2015)  
 
Under 5 Mortality: 




62 years (2014) 
 
 
Global HIV/AIDS Epidemic 
 
Estimated HIV Prevalence 
(Ages 15-49):  5.9% (2015) 
 
Estimated AIDS Deaths  
(Age ≥15): 31,000 (2015) 
 
Estimated Orphans Due to 








Global Tuberculosis  
(TB) Epidemic 
 
TB Treatment Success Rate:  
87% (2015) 
 
Estimated TB Incidence:  
233 /100,000 (2015) 
 
Estimated Who are HIV 
Positive: 33% (2015) 
 
 
Country Staff: 165 
 
Locally Employed Staff: 129 
Direct Hires: 35 
Fellows & Contactors: 1 
 
